CROI 2019 Program and Conference Information

Oral Sessions

115 5:30

TREATINGMULTIDRUG-RESISTANT TUBERCULOSIS IN THE REALWORLD: NEWDRUGS AND REGIMENS Jennifer Furin, Harvard Medical School, Boston, MA, USA

CME

Symposium S-6 THE STORY OF U: IMPLICATIONS OF

UNDETECTABLE VIRAL LOAD ON TRANSMISSION

Room 6AB 4:00 PM - 6:00 PM Target Audience: This session is directed at clinicians and scientists who are interested in HIV transmission risk and mitigating factors, data supporting the lack of transmission risk from persons who are fully virally suppressed, clinical challenges in applying U=U, and community perspectives. Level of Knowledge: It is assumed that the participants are familiar with HIV epidemiology and risk factors for HIV transmission. Objectives: After attending this session, learners will be able to describe Undetectable = Untransmittable with regard to: • Virology and other basic science issues

• Clinical challenges • Social implications

Conveners Eugene McCray, CDC, Atlanta, GA, USA Loice Achieng, University of Nairobi, Nairobi, Kenya 116 THE STORY OF U=U: SCIENTIFIC UNDERPINNINGS 4:00

Pietro L. Vernazza, St Gallen Cantonal Hospital, St Gallen, Switzerland

117 4:30

CARING FOR U: CLINICAL CONUNDRUMS Nneka Nwokolo, Chelsea and Westminster Hospital, London, UK

118 5:00

ME AND U: COMMUNITY PERSPECTIVES Carrie Foote, Indiana University, Bloomington, IN, USA

119 5:30

MORE THAN U: MAXIMIZING POPULATION-LEVEL EFFECTS OF U=U Andrew E. Grulich, University of New South Wales, Sydney, NSW, Australia

Oral Sessions • Wednesday

CROI 2019 52